Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 229792011000036117 | Tazocin 4 g/500 mg powder for injection, 10 x 4.5 g vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 229794011000036114 | Tazocin 4 g/500 mg (piperacillin 4 g + tazobactam 500 mg) powder for injection, 10 x 4.5 g vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazocin 4 g/500 mg powder for injection, 10 x 4.5 g vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Tazocin 4 g/500 mg powder for injection, 10 x 4.5 g vials | Is a | piperacillin 4 g + tazobactam 500 mg injection, 10 x 4.5 g vials | true | Inferred relationship | Some | ||
| Tazocin 4 g/500 mg powder for injection, 10 x 4.5 g vials | has TPUU | Tazocin 4 g/500 mg powder for injection, 4.5 g vial | true | Inferred relationship | Some | 1 | |
| Tazocin 4 g/500 mg powder for injection, 10 x 4.5 g vials | has TP | Tazocin 4 g/500 mg | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tazocin 4 g/500 mg powder for injection, 10 x 4.5 g vials | Is a | True | Tazocin 4 g/500 mg powder for injection, 10 x 4.5 g vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR